アッヴィ 臨床試験
-
Intraoral Administration of Botox in Patients With Dentoalveolar Neuropathic Pain
-
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who
-
Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With
-
BOTOX Effects on Seizure Severity and Susceptibility
-
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
-
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Diseas
-
Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
-
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperpara
-
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia
-
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With
-
Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episo
-
Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma
-
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care A
-
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure
-
A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects,
企業別の治験
ファイザーメルク（MSD）ロシュノバルティスアストラゼネカジョンソン・エンド・ジョンソンブリストル・マイヤーズ スクイブサノフィGSKイーライリリーアッヴィアムジェンバイエルベーリンガーインゲルハイムノボ ノルディスク武田薬品ギリアドモデルナビオンテックリジェネロンバーテックスバイオジェン第一三共アステラス製薬エーザイ大塚製薬セルヴィエインサイトセルトリオンサムスンバイオエピスハンミ薬品ユーハン